Multivariate Analysis of DSS and Prognostic Factors for Patients With Hereditary MTC
| Factor . | HR . | 95% CI . | P Value . |
|---|---|---|---|
| Sex | 1.520 | 0.641–3.603 | 0.342 |
| Age at diagnosis | 1.058 | 1.024–1.093 | 0.0008 |
| Tumor stage III-IV | 7.389 | 2.394–22.813 | 0.0005 |
| H group | 2.103 | 0.718–6.160 | 0.1752 |
| HST group | 14.412 | 3.316–62.635 | 0.0004 |
| Factor . | HR . | 95% CI . | P Value . |
|---|---|---|---|
| Sex | 1.520 | 0.641–3.603 | 0.342 |
| Age at diagnosis | 1.058 | 1.024–1.093 | 0.0008 |
| Tumor stage III-IV | 7.389 | 2.394–22.813 | 0.0005 |
| H group | 2.103 | 0.718–6.160 | 0.1752 |
| HST group | 14.412 | 3.316–62.635 | 0.0004 |
Multivariate Analysis of DSS and Prognostic Factors for Patients With Hereditary MTC
| Factor . | HR . | 95% CI . | P Value . |
|---|---|---|---|
| Sex | 1.520 | 0.641–3.603 | 0.342 |
| Age at diagnosis | 1.058 | 1.024–1.093 | 0.0008 |
| Tumor stage III-IV | 7.389 | 2.394–22.813 | 0.0005 |
| H group | 2.103 | 0.718–6.160 | 0.1752 |
| HST group | 14.412 | 3.316–62.635 | 0.0004 |
| Factor . | HR . | 95% CI . | P Value . |
|---|---|---|---|
| Sex | 1.520 | 0.641–3.603 | 0.342 |
| Age at diagnosis | 1.058 | 1.024–1.093 | 0.0008 |
| Tumor stage III-IV | 7.389 | 2.394–22.813 | 0.0005 |
| H group | 2.103 | 0.718–6.160 | 0.1752 |
| HST group | 14.412 | 3.316–62.635 | 0.0004 |
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
